HUP0203332A3 - Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them - Google Patents

Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them

Info

Publication number
HUP0203332A3
HUP0203332A3 HU0203332A HUP0203332A HUP0203332A3 HU P0203332 A3 HUP0203332 A3 HU P0203332A3 HU 0203332 A HU0203332 A HU 0203332A HU P0203332 A HUP0203332 A HU P0203332A HU P0203332 A3 HUP0203332 A3 HU P0203332A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
receptor modulators
progesterone receptor
cyclothiocarbamate
Prior art date
Application number
HU0203332A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HUP0203332A2 publication Critical patent/HUP0203332A2/hu
Publication of HUP0203332A3 publication Critical patent/HUP0203332A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0203332A 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them HUP0203332A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011749 WO2000066570A1 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (2)

Publication Number Publication Date
HUP0203332A2 HUP0203332A2 (hu) 2003-01-28
HUP0203332A3 true HUP0203332A3 (en) 2004-12-28

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203332A HUP0203332A3 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them

Country Status (24)

Country Link
EP (1) EP1175411B1 (https=)
JP (2) JP4958338B2 (https=)
KR (1) KR100732692B1 (https=)
CN (1) CN1131856C (https=)
AT (1) ATE386729T1 (https=)
AU (1) AU766801B2 (https=)
BG (1) BG65277B1 (https=)
BR (1) BR0010214A (https=)
CA (1) CA2371712C (https=)
CZ (1) CZ20013952A3 (https=)
DE (1) DE60038108T2 (https=)
DK (1) DK1175411T3 (https=)
EA (1) EA004511B1 (https=)
ES (1) ES2301482T3 (https=)
GE (1) GEP20043181B (https=)
HU (1) HUP0203332A3 (https=)
IL (1) IL146298A0 (https=)
MX (1) MXPA01011287A (https=)
NO (1) NO321370B1 (https=)
NZ (1) NZ515353A (https=)
PL (1) PL351083A1 (https=)
SG (1) SG120970A1 (https=)
SK (1) SK15922001A3 (https=)
TR (1) TR200103285T2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386729T1 (de) * 1999-05-04 2008-03-15 Wyeth Corp Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
ATE409699T1 (de) * 2004-04-08 2008-10-15 Wyeth Corp Verfahren zur minimierung von thioamidverunreinigungen
ATE413398T1 (de) * 2004-04-08 2008-11-15 Wyeth Corp Thioamidderivate als progesteronrezeptormodulatoren
EP1756072A2 (en) * 2004-04-27 2007-02-28 Wyeth Purification of progesterone receptor modulators
CA2562160C (en) * 2004-04-27 2013-05-28 Wyeth Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
WO2006014476A1 (en) * 2004-07-07 2006-02-09 Wyeth Cyclic progestin regimens and kits
SI1778710T1 (sl) 2004-08-13 2012-05-31 Wyeth Llc Derivati tanaprogeta metaboliti in njihove uporabe
EP1877059B8 (en) 2005-04-28 2010-05-19 Wyeth a Corporation of the State of Delaware Micronized tanaproget and compostions containing same
JP2008539254A (ja) * 2005-04-28 2008-11-13 ワイス タナプロゲットの精製形態
SI1896034T1 (sl) 2005-04-28 2010-07-30 Wyeth Llc Mikronizirani sestavki tanaprogeta in postopki priprave le-tega
WO2007030153A2 (en) * 2005-04-28 2007-03-15 Wyeth Compositions containing micronized tanaproget
BRPI0610433A2 (pt) * 2005-04-28 2010-11-23 Wyeth Corp forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada
CN103989687A (zh) * 2005-06-09 2014-08-20 惠氏公司 含有炔雌醇的tanaproget组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5696130A (en) * 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Tricyclic steroid receptor modulator compounds and methods
EP1043325B1 (en) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
ES2203790T3 (es) * 1996-10-02 2004-04-16 Bristol-Myers Squibb Pharma Company 1,4-dihidro-2h-3,1-benzoxacin-2-onas 4,4-disustituidas utiles como inhibidores de la transcriptasa reversa del hiv e intermedios y procedimientos para su preparacion.
ATE386729T1 (de) * 1999-05-04 2008-03-15 Wyeth Corp Cyclothiocarbamatderivate als progesteron- rezeptormodulatoren
EP1877059B8 (en) * 2005-04-28 2010-05-19 Wyeth a Corporation of the State of Delaware Micronized tanaproget and compostions containing same
CN103989687A (zh) * 2005-06-09 2014-08-20 惠氏公司 含有炔雌醇的tanaproget组合物

Also Published As

Publication number Publication date
EA004511B1 (ru) 2004-04-29
JP4958338B2 (ja) 2012-06-20
SG120970A1 (en) 2006-04-26
BG106080A (en) 2002-05-31
CA2371712A1 (en) 2000-11-09
JP2012087129A (ja) 2012-05-10
PL351083A1 (en) 2003-03-10
BR0010214A (pt) 2002-02-13
ATE386729T1 (de) 2008-03-15
CN1131856C (zh) 2003-12-24
NZ515353A (en) 2004-03-26
KR100732692B1 (ko) 2007-06-27
IL146298A0 (en) 2002-07-25
CZ20013952A3 (cs) 2002-05-15
BG65277B1 (bg) 2007-11-30
ES2301482T3 (es) 2008-07-01
JP2002543192A (ja) 2002-12-17
AU4811900A (en) 2000-11-17
EP1175411B1 (en) 2008-02-20
DK1175411T3 (da) 2008-06-09
JP5523430B2 (ja) 2014-06-18
EP1175411A1 (en) 2002-01-30
NO20015381L (no) 2002-01-03
KR20020000170A (ko) 2002-01-04
TR200103285T2 (tr) 2002-02-21
CA2371712C (en) 2009-12-22
EA200101181A1 (ru) 2002-04-25
NO321370B1 (no) 2006-05-02
NO20015381D0 (no) 2001-11-02
DE60038108T2 (de) 2009-02-12
GEP20043181B (en) 2004-02-25
AU766801B2 (en) 2003-10-23
HUP0203332A2 (hu) 2003-01-28
DE60038108D1 (de) 2008-04-03
CN1349516A (zh) 2002-05-15
SK15922001A3 (sk) 2002-09-10
MXPA01011287A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
HUP0201243A2 (en) Glucocorticoid receptor modulators, pharmaceutical compositions containing them and their use
HUP0200992A3 (en) Indoline derivatives as progesterone antagonists and pharmaceutical compositions containing them and their use
HUP0300618A3 (en) Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0204557A3 (en) Benzazole derivatives, their use as jnk modulators, their preparation and pharmaceutical compositions containing them
HUP0204245A3 (en) Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203403A3 (en) New imidazole derivatives, pharmaceutical compositions containing them and their use
HUP0203638A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use
HUP0203548A3 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0400540A3 (en) 2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them
HUP0203294A3 (en) Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0105114A3 (en) Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
HUP0204029A3 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HUP0005001A3 (en) Pyrrolidine derivatives as ep 4 receptor selective agonists and pharmaceutical compositions containing them
HUP0105003A3 (en) 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
HUP0300616A3 (en) Adamantane derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0104795A3 (en) Azabicycloalkanes as ccr5 modulators, pharmaceutical compositions comprising thereof and their use
IL148876A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0202731A3 (en) O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201516A3 (en) 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0200996A3 (en) Amine derivatives, pharmaceutical compositions containing them and their use
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0203385A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: WYETH, US

Free format text: FORMER OWNER(S): AMERICAN HOME PRODUCTS CO., US; LIGAND PHARMACEUTICALS, INC., US; WYETH, US

FD9A Lapse of provisional protection due to non-payment of fees